No Nod For Covaxin Yet, WHO Seeks "Additional Clarifications

The World Health Organisation's technical advisory group on Tuesday sought "additional clarifications" from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine.

Related Keywords

India , Bharat , Margaret Harris , Johnson Janssen , Pfizer , Bio Serum Institute Of India , Astrazeneca , Technical Advisory Group , Technical Advisory Group For Emergency Use Listing , Oxford University Covishield , World Health Organisation , Additional Clarifications , Bharat Biotech , Emergency Use Listing , Oxford University , Serum Institute , Covaxin , Covaxin Coronavirus Vaccine ,